Fortis Malar Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve the Un audited Financial Results (Standalone and Consolidated) for quarter and half year ended September 30, 2026

FMHL/SE/BM/OCT’26 October 27, 2026 BSE Limited Department of Corporate Services, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400001 Scrip Code: 523696 Subject: Intimation of Board Meeting under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, In pursuance of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Tuesday, November 03, 2026 inter-alia, to consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026. Further, in continuation to our reference letter FMHL/SEC/2026-2027 dated September 25, 2026, with respect to the ‘Closure of Trading Window’, it is hereby informed that the ‘Trading Window’ for dealing in the Company’s Securities shall remain closed till 48 hours after the announcement of the Financial Results i.e. upto November 05, 2026. This is for your information and record please. The same is also uploaded on the website of the Company. Thanking You, For Fortis Malar Hospitals Limited Vinti Verma Company Secretary & Compliance Officer ICSI Membership No. A44528 FORTIS MALAR HOSPITALS LIMITED Regd. Office: Fortis Hospital, Sector 62, Phase – VIII, Mohali – 160062 Tel: +91 172 4692222 Fax: +91 172 5096002 CIN: L85110PB1989PLC045948 Email: secretarial.malar@malarhospitals.in Website: www.fortismalarhospital.com